Parathyroid hormone and insulin resistance in distinct phenotypes of severe obesity: A cross- sectional analysis in middle-aged men and premenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 12, 2012, Pages 4724-4732

  Bellia, Alfonso ^a   Marinoni, Giorgia ^a   D'Adamo, Monica ^a   Guglielmi, Valeria ^a   Lombardo, Mauro ^b   Donadel, Giulia ^a   Gentileschi, Paolo ^a   Lauro, Davide ^a   Federici, Massimo ^a   Lauro, Renato ^a   Sbraccia, Paolo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Faculty of Architecture and Industrial Design   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CALCIUM; CREATININE; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PARATHYROID HORMONE; PHOSPHORUS; TRIACYLGLYCEROL;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY FAT DISTRIBUTION; BONE DENSITY; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HYPERPARATHYROIDISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PHOSPHATE BLOOD LEVEL; PREMENOPAUSE; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

ADULT; AGE FACTORS; BODY COMPOSITION; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY, MORBID; PARATHYROID HORMONE; PHENOTYPE; PREMENOPAUSE; SEVERITY OF ILLNESS INDEX;

EID: 84870749942     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2513     Document Type: Article

References (38)

1. Hubert HB, Feinleib M, McNamara PM, Castelli WP 1983 Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67:968-977 (Pubitemid 13080473)
2. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, van der Schouw YT, Spencer E, Moons KG, Tjønneland A, Halkjaer J, Jensen MK, Stegger J, Clavel-Chapelon F, Boutron-Ruault MC, Chajes V, Linseisen J, Kaaks R, Trichopoulou A, Trichopoulos D, Bamia C, Sieri S, Palli D, Tumino R, Vineis P, et al. 2008 General and abdominal adiposity and risk of death in Europe. N Engl J Med 359:2105-2120
3. Eckel RH, Kahn R, Robertson RM, Rizza RA 2006 Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation 113:2943-2946 (Pubitemid 44297236)
4. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH; American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism 2006 Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113:898-918
5. Hamoui N, Kim K, Anthone G, Crookes PF 2003 The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery. Arch Surg 138:891-897 (Pubitemid 36960952)
6. Kamycheva E, Sundsfjord J, Jorde R 2004 Serum parathyroid hormone level is associated with body mass index. The 5th Tromsøstudy. Eur J Endocrinol 151:167-172 (Pubitemid 39207010)
7. Bolland MJ, Grey AB, Gamble GD, Reid IR 2005 Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab 90:1525-1530 (Pubitemid 40464014)
8. Adam MA, Untch BR, Danko ME, Stinnett S, Dixit D, Koh J, Marks JR, Olson Jr JA 2010 Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidism. J Clin Endocrinol Metab 95:4917-4924
9. Reis JP, von Mühlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E 2007 Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 30:1549-1555 (Pubitemid 46871169)
10. Sukumar D, Partridge NC, Wang X, Shapses SA 2011 The high serum monocyte chemoattractant protein-1 in obesity is influenced by high parathyroid hormone and not adiposity. J Clin Endocrinol Metab 96:1852-1858
11. Gilardini L, Pasqualinotto L, Di Matteo S, Caffetto K, Croci M, Girola A, Invitti C 2011 Factors associated with early atherosclerosis and arterial calcifications in young subjects with a benign phenotype of obesity. Obesity 19:1684-1689
12. Hjelmesaeth J, Hofsø D, Aasheim ET, Jenssen T, Moan J, Hager H, Røislien J, Bollerslev J 2009 Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol 8:7
13. Lundgren E, Ljunghall S, Akerström G, Hetta J, Mallmin H, Rastad J 1998 Case-control study on symptoms and signs of "asymptomatic"primary hyperparathyroidism. Surgery 124:980-985; discussion 985-986
14. Ljunghall S, Palmér M, Akerström G, Wide L 1983 Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy. Eur J Clin Invest 13:373-377 (Pubitemid 13014013)
15. Farahnak P, Lärfars G, Sten-Linder M, Nilsson IL 2011 Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers. J Clin Endocrinol Metab 96:2112-2118
16. Hedbäck GM, Odén AS 2002 Cardiovascular disease, hypertension and renal function in primary hyperparathyroidism. J Intern Med 251:476-483 (Pubitemid 34537310)
17. S Hagström E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundström J, Melhus H, Held C, Lind L, Michaëlsson K, Arnlöv J 2009 Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119:2765-2771
18. Sambrook PN, Chen JS, March LM, Cameron ID, Cumming RG, Lord SR, Schwarz J, Seibel MJ 2004 Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 89:5477-5481 (Pubitemid 39518428)
19. Taylor EN, Curhan GC, Forman JP 2008 Parathyroid hormone and the risk of incident hypertension. J Hypertens 26:1390-1394
20. Marini MA, Succurro E, Frontoni S, Hribal ML, Andreozzi F, Lauro R, Perticone F, Sesti G 2007 Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care 30:2145-2147 (Pubitemid 47219439)
21. Sims EA 2001 Are there persons who are obese, but metabolically healthy? Metabolism 50:1499-1504 (Pubitemid 34007425)
22. Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud'homme D, Rabasa-Lhoret R 2005 The metabolically healthy but obese individual presents a favourable inflammation profile. J Clin Endocrinol Metab 90:4145-4150 (Pubitemid 41058189)
23. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET 2004 Metabolic and body composition factors in subgroups of obesity. J Clin Endocrinol Metab 89:2569-2575 (Pubitemid 38766333)
24. Ford ES, Giles WH, Dietz WH 2002 Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287:356-359 (Pubitemid 34251969)
25. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470 (Pubitemid 29135798)
26. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470 (Pubitemid 29418240)
27. Alberti KG, Zimmet PZ 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 15:539-553 (Pubitemid 28319935)
28. Adams JS, Hewison M 2010 Update in Vitamin D. J Clin Endocrinol Metab 95:471-478
29. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ 1997 Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7:439-443 (Pubitemid 27443069)
30. Hayes L, Pearce MS, Firbank MJ, Walker M, Taylor R, Unwin NC 2010 Do obese but metabolically normal women differ in intraabdominal fat and physical activity levels from those with the expected metabolic abnormalities? A cross-sectional study. BMC Public Health 10:723
31. Arunabh S, Pollack S, Yeh J, Aloia JF 2003 Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 88:157-161 (Pubitemid 36115158)
32. Vilarrasa N, Maravall J, Estepa A, Sánchez R, Masdevall C, Navarro MA, Alía P, Soler J, Gómez JM 2007 Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 30:653-658 (Pubitemid 350104094)
33. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL, Robins SJ, O'Donnell CJ, Hoffmann U, Jacques PF, Booth SL, Vasan RS, Wolf M, Wang TJ 2010 Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 59:242-248
34. Narvaez CJ, Matthews D, Broun E, Chan M, Welsh J 2009 Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology 150:651-661
35. Wong KE, Szeto FL, Zhang W, Ye H, Kong J, Zhang Z, Sun XJ, Li YC 2009 Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physiol Endocrinol Metab 296:E820-E828
36. Kuchuk NO, van Schoor NM, Pluijm SM, Chines A, Lips P 2009 Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J Bone Miner Res 24:693-701
37. Ahlström T, Hagström E, Larsson A, Rudberg C, Lind L, Hellman P 2009 Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women. Clin Endocrinol (Oxf) 71:673-678
38. Messier V, Karelis AD, Prud'homme D, Primeau V, Brochu M, Rabasa-Lhoret R 2010 Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity 18:911-917